GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice (2017)
Huang, Sammen; Wang, Haitao; Turlova, Ekaterina; Abussaud, Ahmed; Ji, Xiang; Britto, Luiz Roberto Giorgetti de 
; Miller, Steven P.; Martinez, Ana; Sun, Hong‐Shuo; Feng, Zhong‐Ping
Source: CNS Neuroscience & Therapeutics. Unidade: ICB
Assunto: FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUANG, Sammen et al. GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice. CNS Neuroscience & Therapeutics, v. 23, n. 5, p. 405-415, 2017Tradução . . Disponível em: https://doi.org/10.1111/cns.12683. Acesso em: 15 maio 2024.APA
Huang, S., Wang, H., Turlova, E., Abussaud, A., Ji, X., Britto, L. R. G. de, et al. (2017). GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice. CNS Neuroscience & Therapeutics, 23( 5), 405-415. doi:10.1111/cns.12683NLM
Huang S, Wang H, Turlova E, Abussaud A, Ji X, Britto LRG de, Miller SP, Martinez A, Sun H‐S, Feng Z‐P. GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice [Internet]. CNS Neuroscience & Therapeutics. 2017 ; 23( 5): 405-415.[citado 2024 maio 15 ] Available from: https://doi.org/10.1111/cns.12683Vancouver
Huang S, Wang H, Turlova E, Abussaud A, Ji X, Britto LRG de, Miller SP, Martinez A, Sun H‐S, Feng Z‐P. GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice [Internet]. CNS Neuroscience & Therapeutics. 2017 ; 23( 5): 405-415.[citado 2024 maio 15 ] Available from: https://doi.org/10.1111/cns.12683
